|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2247304 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09727180.3 |
| Date of filing the European patent application | 2009-03-25 | |
| (97) | Date of publication of the European application | 2010-11-10 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-25 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (86) | Number | PCT/US2009/038201 |
| Date | 2009-03-25 |
| (87) | Number | WO 2009/123894 |
| Date | 2009-10-08 |
| (30) | Number | Date | Country code |
| 41649 P | 2008-04-02 | US |
| (72) |
JOHNSON, Leslie, S., US
HUANG, Ling, US
TUAILLON, Nadine, US
BONVINI, Ezio, US
|
| (73) |
MacroGenics, Inc.,
9704 Medical Center Drive, Rockville, MD 20850,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | HER2/neu atžvilgiu specifiniai antikūna ir jų panaudojimo būdai |
| HER2/NEU-SPECIFIC ANTIBODIES AND METHODS OF USING SAME |
| Payment date | Validity (years) | Amount | |
| 2022-02-18 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-25 |